等待开盘 11-19 09:30:00 美东时间
+0.060
+0.20%
Viridian Therapeutics, Inc. (($VRDN)) has held its Q3 earnings call. Read on fo...
11-15 09:19
今日重点评级关注:花旗:维持Faeth Therapeutics"买入"评级,目标价从55美元升至60美元;HC Wainwright & Co.:维持Ocular Therapeutix"买入"评级,目标价从25美元升至28美元
11-11 10:50
Viridian Therapeutics ( ($VRDN) ) has provided an update. On November 9, 2026, ...
11-09 20:58
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Needham raised the price target for Pattern Group Inc (NASDAQ:PTRN) from $29 to $32. Needham analyst Bernie Mc...
11-05 21:22
今日重点评级关注:康托·菲茨杰拉德:维持Supernus"超配"评级,目标价从67美元升至87美元;丰业银行:维持Atlas Energy Solutions"跑赢大市"评级,目标价从17美元升至18美元
11-05 14:06
Needham analyst Serge Belanger maintains Viridian Therapeutics (NASDAQ:VRDN) with a Buy and raises the price target from $34 to $38.
11-05 04:48
Viridian Therapeutics shares are trading higher after the company reported better-than-expected Q3 EPS results.
11-04 22:16
华盛资讯11月4日讯,Viridian Therapeutics, Inc.公布2026财年Q3业绩,公司Q3营收0.26亿美元,同比下降63.5%,归母净利润亏损1.01亿美元,同比亏损扩大192.5%。
11-04 20:45
华盛资讯11月4日讯,Viridian Therapeutics, Inc.公布2026财年Q3业绩,公司Q3营收0.26亿美元,同比下降63.5%,归母净利润亏损1.01亿美元,同比亏损扩大192.5%。
11-04 20:37
Viridian Therapeutics (NASDAQ:VRDN) reported quarterly losses of $(0.81) per share which beat the analyst consensus estimate of $(1.00) by 19 percent. This is a 138.24 percent decrease over losses of $(0.34) per share from the same period last year. The company reported quarterly sales of $25.752 th...
11-04 20:04